MAZZAFERRO, VINCENZO MARIA
MAZZAFERRO, VINCENZO MARIA
Dipartimento di Oncologia ed Emato-Oncologia
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study
2014 M. Angelico, A. Nardi, R. Romagnoli, T. Marianelli, S.G. Corradini, F. Tandoi, C. Gavrila, M. Salizzoni, A.D. Pinna, U. Cillo, B. Gridelli, L.G. De Carlis, M. Colledan, G.E. Gerunda, A.N. Costa, M. Strazzabosco, M. Angelico, U. Cillo, S. Fagiuoli, M. Strazzabosco, P. Caraceni, P.L. Toniutto, T.M. Sal-izzoni, R. Romagnoli, G. Bertolotti, D. Patrono, L. Decarlis, A. Slim, J.M.E. Mangoni, G. Rossi, L. Caccamo, B. Antonelli, V. Mazzaferro, E. Regalia, C. Sposito, M. Colledan, V. Corno, S. Marin, U. Cillo, A. Vitale, E. Gringeri, M. Donataccio, D. Donataccio, U. Baccarani, D. Lorenzin, D. Bitetto, U. Valente, M. Gelli, P. Cupo, G.E. Gerunda, G. Rompianesi, A.D. Pinna, G.L. Grazi, A. Cucchetti, C. Zanfi, A. Risaliti, M.G. Faraci, G. Tisone, A. Anselmo, I. Lenci, D. Sforza, S. Agnes, M. Di Mugno, A.M. Avolio, G.M. Ettorre, L. Miglioresi, G. Vennarecci, P. Berloco, M. Rossi, G. Corradini, A. Molinaro, F. Calise, V. Scuderi, O. Cuomo, C. Migliaccio, L. Lupo, G. Notarnicola, B. Gridelli, R. Volpes, S. Lipetri, G. Zamboni, G. Carbotta, S. Dedola
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors
2018 S. Pusceddu, F. Barretta, A. Trama, L. Botta, M. Milione, R. Buzzoni, F. De Braud, V. Mazzaferro, U. Pastorino, E. Seregni, L. Mariani, G. Gatta, M. Di Bartolomeo, D. Femia, N. Prinzi, J. Coppa, F. Panzuto, L. Antonuzzo, E. Bajetta, M. Pia Brizzi, D. Campana, L. Catena, H. Comber, F. Dwane, N. Fazio, A. Faggiano, D. Giuffrida, K. Henau, T. Ibrahim, R. Marconcini, S. Massironi, M.P. Zakelj, F. Spada, S. Tafuto, E. Van Eycken, J.M. Van Der Zwan, T. Zagar, L. Giacomelli, R. Miceli
A clinicopathologic study of primary hepatic carcinoid tumors
1990 S. Andreola, L. Lombardi, R.A. Audisio, V. Mazzaferro, D. Koukouras, R. Doci, L. Gennari, L. Makowka, T.E. Starzl, D.H. van Thiel
A Combined Approach to Priorities of Surgical Oncology During the COVID-19 Epidemic
2020 V. Mazzaferro, P. Danelli, G. Torzilli, M. Droz Dit Busset, M. Virdis, C. Sposito
A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with90Y glass microspheres
2012 C. Chiesa, M. Mira, M. Maccauro, R. Romito, C. Spreafico, C. Sposito, S. Bhoori, C. Morosi, S. Pellizzari, A. Negri, E. Civelli, R. Lanocita, T. Camerini, C. Bampo, M. Carrara, E. Seregni, A. Marchiano, V. Mazzaferro, E. Bombardieri
A Longitudinal Investigation of Posttraumatic Growth and Quality of Life in Liver Transplant Recipients
2018 L. Gangeri, M. Scrignaro, E. Bianchi, C. Borreani, S. Bhoorie, V. Mazzaferro
A Matched Pair Analysis of Multicenter Long-term Follow-up after Split Liver Transplantation with Extended Right Grafts
2017 M.W. Ross, M. Cescon, R. Angelico, E. Andorno, G.E. Rossi, A. Pinna, L. De Carlis, U. Baccarani, U. Cillo, M. Colledan, V.M. Mazzaferro, G. Tisone, M. Rossi, F. Tuzzolino, D. Pagano, S. Gruttadauria, G. Mazariegos, B. Gridelli, M. Spada
A modified technique of orthotopic transplant of the kidney in rabbits
1989 V. Mazzaferro, L. Makowka, F. Enrichens, D. Kahn, G. Ferla, B. Banner, G. Olivero, R.R. Selby, W.C. Stevenson, S. Todo, T.E. Starzl
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
2006 J.M. Llovet, Y. Chen, E. Wurmbach, S. Roayaie, M.I. Fiel, M. Schwartz, S.N. Thung, G. Khitrov, W. Zhang, A. Villanueva, C. Battiston, V. Mazzaferro, J. Bruix, S. Waxman, S.L. Friedman
A multicenter italian experience in spli-liver transplantation : 10 year follow-up of a case control study
2010 M. Spada, D. Pagano, M. Colledan, M. Cescon, G. Rossi, U. Baccarani, G. Tisone, E. Adorno, L. De Carlis, U. Cillo, V. Mazzaferro, M. Rossi, S. Gruttadauria, B. Gridelli
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation : toward a "blended Principle Model"
2015 U. Cillo, P. Burra, V. Mazzaferro, L. Belli, A.D. Pinna, M. Spada, A. Nanni Costa, P. Toniutto
A national mandatory-split liver policy: A report from the Italian experience
2019 R. Angelico, S. Trapani, M. Spada, M. Colledan, J. de Ville de Goyet, M. Salizzoni, L. De Carlis, E. Andorno, S. Gruttadauria, G. Ettorre, M. Cescon, G. Rossi, A. Risaliti, G. Tisone, U. Tedeschi, M. Vivarelli, S. Agnes, P. De Simone, L. Lupo, F. Di Benedetto, W. Santaniello, F. Zamboni, V. Mazzaferro, M. Rossi, F. Puoti, S. Camagni, C. Grimaldi, E. Gringeri, L. Rizzato, A. Nanni Costa, U. Cillo
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group
1995 M. Di Bartolomeo, E. Bajetta, A.M. Bochicchio, C. Carnaghi, L. Somma, V. Mazzaferro, M. Visini, V. Gebbia, S. Tumolo, P. Ballatore
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study
2014 P. Aseni, T.M. De Feo, L. De Carlis, U. Valente, M. Colledan, U. Cillo, G. Rossi, V. Mazzaferro, M. Donataccio, N. De Fazio, E. Andorno, P. Burra, A. Giacomoni, A.O. Slim, C. Sposito, A. De Gasperi, B. Antonelli, G. Zanus, D. Pinelli, M. Zambelli, N. Morelli, R. Valente, G. Grosso, M. Mantovani, G. Piccolo
A prospective randomized, open-labeled; trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
2010 A. Schnitzbauer, C. Zuelke, C. Graeb, J. Rochon, I. Bilbao, P. Burra, K.P. De Jong, C. Duvoux, N.M. Kneteman, R. Adam, W.O. Bechstein, T. Becker, S. Beckebaum, O. Chazouilleres, U. Cillo, M. Colledan, F. Fandrich, J. Gugenheim, J.P. Hauss, M. Heise, E. Hidalgo, N. Jamieson, A. Konigsrainer, P.E. Lamby, J.P. Lerut, H. Makisalo, R. Margreiter, V. Mazzaferro, I. Mutzbauer, G. Otto, G.P. Pageaux, A.D. Pinna, J. Pirenne, M. Rizell, G.E. Rossi, L. Rostaing, A. Roy, V. Sanchez Turrion, J. Schimdt, R. Troisi, B. Van Hoek, U. Valente, P. Wolf, H. Wolters, D.F. Mirza, T. Scholz, R. Steininger, G. Soderdahl, S.L. Strasser, K.W. Jauch, P. Neuhaus, H.J. Schlitt, E.K. Geissler
Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma
2022 M. Niger, F. Nichetti, F. Dell'Angelo, V. Cappelletti, C. Pircher, M. Vismara, C. Cotsoglou, S. Bhoori, A. Vingiani, M. Di Bartolomeo, F. Pietrantonio, F.G.M. DE BRAUD, G. Pruneri, M. Grazia Daidone, V.M. Mazzaferro
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy : a phase II ITMO study
2014 R. Buzzoni, S. Pusceddu, E. Bajetta, F. De Braud, M. Platania, C. Iannacone, M. Cantore, A. Mambrini, A. Bertolini, O. Alabiso, A. Ciarlo, C. Turco, V. Mazzaferro
Adjuvant radiotherapy in urothelial neuroendocrine carcinoma
2020 R.E. Rossi, M. Monteleone, M. Altomare, L. Cattaneo, M. Torchio, J. Coppa, V. Mazzaferro
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM) : a phase 3, randomised, double-blind, placebo-controlled trial
2015 J. Bruix, T. Takayama, V. Mazzaferro, G.Y. Chau, J. Yang, M. Kudo, J. Cai, R.T. Poon, K.H. Han, W. Young Tak, H. Chu Lee, T. Song, S. Roayaie, L. Bolondi, K. Sik Lee, M. Makuuchi, F. Souza, M. Aude Le Berre, G. Meinhardt, J.M. Llovet
Alpha-Fetoprotein (AFP) in liver transplantation for HCC: The lower, the better
2018 V. Mazzaferro, M. Droz Dit Busset, S. Bhoori